The Biotech Company That's Training Immune Cells To Fight Cancer

Comments
Loading...

Photo by National Cancer Institute on Unsplash

Dr. Henry Ji, President and CEO of Sorrento Therapeutics SRNE, was a guest speaker at Benzinga’s All Access on March 25, 2022. 

Sorrento Therapeutics is a biotechnology company researching and developing innovative solutions to diseases like cancer, intractable pain and COVID-19.

Watch the full interview here:

Market News and Data brought to you by Benzinga APIs

Posted In: